Platelet depletion in experimental myocardial infarction
- PMID: 4026785
- DOI: 10.1007/BF01907903
Platelet depletion in experimental myocardial infarction
Abstract
Accumulation of platelets in the microvasculature after acute myocardial ischemia may exacerbate tissue injury through the formation of microthrombi and by the release of vasoactive substances. To assess the role of platelets in myocardial ischemic injury and infarction, circulating platelets were reduced by 94 +/- 2% (mean +/- S.E.M.) with sheep antiserum to canine platelets. Regional myocardial ischemia was produced by occlusion of the left circumflex coronary artery (LCCA) for 90 min followed by reperfusion for 5 hours. Infarct size did not differ significantly between antiplatelet serum and nonimmune serum groups: 36 +/- 8 vs. 43 +/- 4% of the area at risk, determined by a post-mortem dual staining technique (p greater than 0.05). A second occlusion-reperfusion control group, sacrificed at 24 hours, did not differ from 5 hr reperfused groups with regard to infarct size. Coronary sinus thromboxane B2 (TXB2) concentrations were not altered significantly by platelet depletion. Histopathologic examination confirmed the presence of necrosis in the infarcted myocardium and revealed substantial leukocytic infiltration in both groups. The results suggest that circulating platelets are not required for the full expression of myocardial ischemic injury resulting from temporary coronary artery occlusion followed by reperfusion.
Similar articles
-
Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs.J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):733-8. doi: 10.1097/00005344-198507000-00018. J Cardiovasc Pharmacol. 1985. PMID: 2410715
-
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation. 1983 May;67(5):1016-23. doi: 10.1161/01.cir.67.5.1016. Circulation. 1983. PMID: 6831665
-
Neutrophil depletion suppresses 111In-labeled platelet accumulation in infarcted myocardium.J Cardiovasc Pharmacol. 1985 Sep-Oct;7(5):906-12. doi: 10.1097/00005344-198509000-00014. J Cardiovasc Pharmacol. 1985. PMID: 2413299
-
Platelets in Myocardial Ischemia/Reperfusion Injury.Hamostaseologie. 2023 Apr;43(2):110-121. doi: 10.1055/a-1739-9351. Epub 2022 Jul 29. Hamostaseologie. 2023. PMID: 35913081 Free PMC article. Review.
-
Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury.Cardiol Res Pract. 2021 May 24;2021:5545416. doi: 10.1155/2021/5545416. eCollection 2021. Cardiol Res Pract. 2021. PMID: 34123416 Free PMC article. Review.
Cited by
-
Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactions.Cardiovasc Drugs Ther. 1988 May;2(1):35-40. doi: 10.1007/BF00054250. Cardiovasc Drugs Ther. 1988. PMID: 3154692 Review.
-
The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.Basic Res Cardiol. 1991 Mar-Apr;86(2):99-106. doi: 10.1007/BF02190542. Basic Res Cardiol. 1991. PMID: 1831610
-
Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.Mol Cell Biochem. 1993 Feb 17;119(1-2):133-41. doi: 10.1007/BF00926864. Mol Cell Biochem. 1993. PMID: 7681140
-
Protease-activated receptors and myocardial infarction.IUBMB Life. 2011 Jun;63(6):383-9. doi: 10.1002/iub.441. Epub 2011 Mar 24. IUBMB Life. 2011. PMID: 21438116 Free PMC article. Review.
-
Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.Cardiovasc Drugs Ther. 2023 Oct;37(5):865-876. doi: 10.1007/s10557-022-07345-9. Epub 2022 May 21. Cardiovasc Drugs Ther. 2023. PMID: 35595877 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical